for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

AstraZeneca expects higher H2 sales as Q1 sales, earnings beat forecasts

April 30 (Reuters) - AstraZeneca said on Friday it expected higher sales in the second half of the year, as it reported first-quarter profit and sales ahead of analysts’ average expectations, including $275 million in COVID-19 vaccine sales.

Reporting by Pushkala Aripaka in Bengaluru and Ludwig Burger in Frankfurt; editing by John Stonestreet

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up